Companion Diagnostics
Roche to Develop Companion Diagnostic Test to Help Identify Patients Eligible for Anti-PD-1 Therapy Based on Biomarker Expression, Not Location, of Solid Tumors
Roche
PR-M12-18-NI-050Dec 14, 2018
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's New Effort for Developing and Class Labeling of In Vitro Companion Diagnostics for Classes of Oncology Therapeutic Products
U.S. Food & Drug Administration
PR-M12-18-NI-034Dec 11, 2018
Collaboration
QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics
Qiagen
PR-M08-18-NI-034Aug 09, 2018